Jonathan Crawford Delong, MD
Surgical Oncology · Knoxville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 13 years
- Eastern Virginia Medical School, 2013
Offices
1 location · University Health System, Inc. · 512 clinicians in this group
Hospitals listed: University of Tn Medical Center (the). That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Delong’s office at (865) 544-9218 to ask if they take your plan before you enroll.
California Medical Board record
Licence A134525 · Current
Licensed to practise in California · since 2015 · expires 2027-02-28 · Eastern Virginia Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Surgery - Surgery
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- University Health System, IncKnoxville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Tennessee Medical CenterPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.44 (1.21 to 1.66), Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 218.76 (187.01 to 250.5) · 354 cases, Jul 2022 – Jun 2024Worse than the national rate — In-hospital fall-associated fracture rate: 0.47 (0.3 to 0.65) · 12,153 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.78 (1.3 to 2.26) · 9,199 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.33, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.515, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.348, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.451, Oct 2024 – Sep 2025
See every measure and the patient survey for University Health System, Inc
Behind the star rating — Deaths: 0 better, 6 the same, 2 worse of 8 measures. Safety: 4 better, 3 the same, 1 worse of 8 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.44 (1.21 to 1.66) | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 218.76 (187.01 to 250.5) · 354 cases | Worse | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.47 (0.3 to 0.65) · 12,153 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.78 (1.3 to 2.26) · 9,199 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.33 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.515 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.348 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.451 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0.09 to 1.7) · 2,368 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 594 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.8 · 789 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 884 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.09 to 0.45) · 11,971 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.04 (2.5 to 5.59) · 3,895 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.26 (0 to 2.58) · 1,688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.27 (2.11 to 4.42) · 3,577 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.5 (5.11 to 13.89) · 1,582 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.41 (3.78 to 9.04) · 1,624 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.51 (1.15 to 3.88) · 761 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 77 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.975 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.556 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 331 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 1,165 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -9.6 · 169 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.7 · 713 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 4.2 · 884 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 1,517 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (3.4 to 5.8) · 744 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (9.6 to 13.4) · 744 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 194 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 369 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.2 to 15.1) · 2,004 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,378 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,645 patients answered, 20% of those asked)
| Cleanliness | 2 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$68,655
Medicare paid this office $68,655 for 75 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 27 | $4,251 | $157 |
| Long return visit (40+ min) | 20 | $3,441 | $127 |
| Repair of abdomen using abdominal lining graft | 12 | $2,563 | $214 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $2,063 | $36 |
| Return visit (30+ min) | 16 | $1,979 | $94 |
See all 7 services
| New patient visit (60+ min) | 27 | $4,251 | $157 |
| Long return visit (40+ min) | 20 | $3,441 | $127 |
| Repair of abdomen using abdominal lining graft | 12 | $2,563 | $214 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $2,063 | $36 |
| Return visit (30+ min) | 16 | $1,979 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,152 | $96 |
| Ultrasonic guidance during surgery | 11 | $400 | $33 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Repair of abdomen using abdominal lining graft | – | – | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
75 Original Medicare patients in 2024. Average age 72 · Women 51% · Health risk score 1.65. Above the middle of the specialty; the typical surgical oncology clinician is at 1.48.
Conditions among them: High blood pressure 75% · Diabetes 44% · Depression 44% · Coronary heart disease 33% · Chronic kidney disease 31% · Cancer 27% · Atrial fibrillation 27% · Heart failure 24% · COPD 21%.
The office billed $308,093, Medicare allowed $86,261 and paid $68,655; for 330 services of 61 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 75 | 330 | 72 | 1.65 | $308,093 | $68,655 |
| 2023 | 27 | 40 | 74 | 1.31 | $118,560 | $9,190 |
| 2022 | 43 | 71 | 72 | 1.44 | $258,177 | $13,998 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Drugs they prescribed that Part D paid
$10,299
Pharmacies billed $10,299 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
57 generic and fewer than 11 brand-name prescriptions · $10,299 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mirtazapine | 18 | $206 | $11 |
Year by year
| 2024 | 62 | 23 | None | None | $10,299 |
| 2022 | 15 | None | None | None | $2,573 |
| 2021 | 32 | 23 | 63% (20) | None | $826 |
| 2020 | 72 | 45 | 51% (37) | None | $2,219 |
| 2019 | 42 | 36 | 71% (30) | 0% | $250 |
| 2018 | 27 | 15 | None | None | $2,755 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 1 drug
| Oxycodone | 19 | $99 | $5 |
2020: 1 drug
| Oxycodone | 33 | $184 | $6 |
2019: 1 drug
| Oxycodone | 22 | $121 | $6 |
Money from drug and device companies
$7,889 in 2025
| 2025 | 13 | 22 | $5,348 | $7,889 |
| 2024 | 11 | 21 | $2,302 | $3,421 |
| 2023 | 7 | 14 | None | $853 |
| 2022 | 3 | 3 | None | $410 |
| 2021 | 1 | 2 | None | $403 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CMR Surgical | Versius Surgical System (Versius Plus) | $6,799 | 9 payments
|
| Stryker | 1788 | $692 | 1 payment
|
| W. L. Gore & Associates | Gore Synecor Preperitoneal Biomaterial | $127 | 1 payment
|
| Biocircuit Technologies | Nerve Tape | $76 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $30 | 2 payments
|
| Tempus AI | Xt Cdx | $30 | 1 payment
|
See all 22 published payments
| Syndax Pharmaceuticals | Meals · 2025-11-17 | None | $19 |
| Ethicon US | Meals · 2025-10-30 | Ethicon | $22 |
| CMR Surgical | Meals · 2025-10-14 | Versius Surgical System (Versius Plus) | $92 |
| Caris MPI | Meals · 2025-09-30 | Mi Cancer Seek | $17 |
| Stryker | Travel · 2025-09-21 | 1788 | $692 |
| CMR Surgical | Meals · 2025-08-12 | Versius Surgical System (Versius Plus) | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-07 | Tagrisso | $15 |
| Biocircuit Technologies | Meals · 2025-07-18 | Nerve Tape | $76 |
| Janssen Biotech | Meals · 2025-05-14 | Tecvayli | $14 |
| Exelixis | Meals · 2025-04-23 | Cabometyx | $18 |
| W. L. Gore & Associates | Meals · 2025-04-23 | Gore Synecor Preperitoneal Biomaterial | $127 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-17 | Tagrisso | $15 |
| CMR Surgical | Travel · 2025-03-10 | Versius Surgical System (Versius Plus) | $473 |
| CMR Surgical | Travel · 2025-03-10 | Versius Surgical System (Versius Plus) | $9 |
| CMR Surgical | Travel · 2025-03-10 | Versius Surgical System (Versius Plus) | $671 |
| CMR Surgical | Travel · 2025-03-10 | Versius Surgical System (Versius Plus) | $13 |
| Merck Sharp & Dohme | Meals · 2025-01-14 | Keytruda | $26 |
| Kerecis | Meals · 2025-01-14 | Kerecis Surgiclose | $18 |
| Tempus AI | Meals · 2025-01-13 | Xt Cdx | $30 |
| CMR Surgical | Consulting · 2025-01-11 | Versius Surgical System (Versius Plus) | $1,163 |
| CMR Surgical | Consulting · 2025-01-11 | Versius Surgical System (Versius Plus) | $4,185 |
| CMR Surgical | Travel · 2025-01-11 | Versius Surgical System (Versius Plus) | $169 |
See earlier years (2024, 2023, 2022, 2021)
2024: $3,421
| FUJIFILM Healthcare Americas | Synapse 3d | $2,645 | 5 payments
|
| Medtronic | Signia | $241 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $195 | 3 payments
|
| BK Medical Holding Company | Bk3000, Bk3500 & Bk5000 Ultrasound System | $110 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $89 | 4 payments
|
| Stryker | 1688 | $52 | 1 payment
|
| Tempus AI | Xt Cdx | $20 | 1 payment
|
| Boston Scientific | Spaceoar Vue System - 10ml | $20 | 1 payment
|
| GlaxoSmithKline | Ojjaara | $19 | 1 payment
|
| Pfizer | Ibrance | $17 | 1 payment
|
| Jazz Pharmaceuticals | Zepzelca | $14 | 1 payment
|
2023: $853
| FUJIFILM Healthcare Americas | Synapse 3d | $298 | 3 payments
|
| Dilon Technologies | Hemoblast Bellows | $188 | 3 payments
|
| Ethicon US | Echelon Flex | $153 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $143 | 3 payments
|
| Novartis Pharmaceuticals | Promacta | $33 | 1 payment
|
| Seagen | Tukysa | $20 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $19 | 1 payment
|
2022: $410
| Medtronic | Signia | $176 | 1 payment
|
| Boston Scientific | General - Biliary Devices | $124 | 1 payment
|
| FUJIFILM Healthcare Americas | Synapse Enterprise Viewer | $110 | 1 payment
|
2021: $403
| AngioDynamics | Solero | $403 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 95.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114365418
- Licence
- CA A134525California A134525: Current · expires 2027-02-28
- Trained
- Eastern Virginia Medical School, 2013 · 13 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Surgery (208600000X)
- Mailing address
- 200 W Arbor Dr, Mc 8220, San Diego, CA, 92103
- NPI first listed
- 2013-06-07
- NPI last updated
- 2021-08-18
- NPI record certified
- 2021-08-18
This is when the NPI record was last certified, not a medical board exam.